Bacteriophage Str-PAP-1 Composition for Streptococcus parauberis Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for preventing and treating Streptococcus parauberis infections in aquaculture are inadequate due to antibiotic resistance and the limitations of existing vaccines, necessitating a more effective and specific treatment approach.
Innovation Solution
Development of a composition containing the isolated bacteriophage Str-PAP-1, which specifically targets and kills Streptococcus parauberis cells, offering a nature-friendly alternative to antibiotics.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If antibiotics are used for preventing and treating Streptococcus parauberis infections, then treatment effectiveness is improved, but antibiotic resistance develops and side effects on beneficial bacteria occur
Solution Approach 1:
The patent uses bacteriophage as an intermediary substance to treat Streptococcus parauberis infections. The bacteriophage specifically targets and infects the pathogenic bacteria, acting as a mediator between the treatment goal and the bacterial target, thereby avoiding the harmful effects of antibiotics while maintaining treatment effectiveness
Solution Approach 2:
The bacteriophage treatment exhibits local quality by being highly specific to Streptococcus parauberis. The bacteriophage only infects and kills the target pathogen without affecting beneficial bacteria, creating a localized therapeutic effect that spares other microbial populations from harm
2Reliability
If vaccines are developed to control Streptococcus parauberis infections, then prevention capability is improved, but the variety of vaccines cannot catch up with the variety of diseases
Solution Approach 1:
The bacteriophage composition demonstrates universality by effectively treating multiple strains of Streptococcus parauberis. A single bacteriophage preparation can target various strains of the pathogen, providing broad-spectrum protection against streptococcosis without requiring multiple specialized vaccines for different disease variants
3Adaptability or versatility
If combined control methods are used to treat multiple diseases simultaneously, then disease coverage is improved, but treatment complexity increases
Solution Approach 1:
The bacteriophage composition provides multi-functional disease control by targeting multiple strains of Streptococcus parauberis simultaneously. This single intervention can address various manifestations of streptococcosis, reducing the need for multiple separate treatments and simplifying the overall disease management protocol
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The bacteriophage composition effectively prevents and treats Streptococcus parauberis infections with high specificity, reducing side effects on beneficial bacteria and improving aquaculture productivity by inhibiting bacterial growth and alleviating symptoms.
Implementation Method 1
Once it infects bacteria, the bacteriophage is proliferated in the inside of the bacterial cell. After full proliferation, the progenies destroy the bacterial cell wall to escape from the host, suggesting that the bacteriophage has bacteria killing ability.
Data Source
AI summary
A composition includes an isolated bacteriophage Str-PAP-1 having the ability to kill Streptococcus parauberis cells specifically by infecting the same, and may be used to prevent and treat Streptococcus parauberis infections. The bacteriophage Str-PAP-1 that is an active ingredient of the composition has the ability to kill Streptococcus parauberis cells and characteristically has the genome represented by nucleotide sequence of SEQ. ID. NO: 1.